US 11505591
T-cell modulatory multimeric polypeptides and methods of use thereof
granted A61KA61K38/00A61K39/3955
Quick answer
US patent 11505591 (T-cell modulatory multimeric polypeptides and methods of use thereof) held by Cue Biopharma, Inc. expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cue Biopharma, Inc.
- Grant date
- Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61K39/3955, A61K48/00, A61P